Abstract
Successful endocrine therapy in breast cancer has been theorized to be dependent upon retention by the tumor of at least part of the cell’s differentiated endocrine functions (1). Estrogen receptors (ER) therefore have been measured extensively in breast tumor biopsies in numerous laboratories as a potential marker of a functional endocrine system. Accordingly, tumors containing ER are much more likely to respond to endocrine therapies than tumors without ER (2). ER alone however is not a totally reliable marker of tumor sensitivity to hormones since certain tumors containing ER do not respond to endocrine manipulations. This is not surprising however, considering that binding of the hormone to the estrogen receptor is only the first step in a complex biochemical pathway leading to the physiological effect of estrogens (3). Any number of points in the pathway may conceivably be missing or defective. For this reason, we hypothesized that an end product of estrogen stimulation would improve the reliability of ER as a marker of hormone-responsive tumor growth (4). Progesterone receptor (PgR) is a likely candidate since it has been shown to be regulated by estrogens in animal mammary tumor models (5, 6) and in human breast cancer cells in tissue culture (7). Simultaneous measurement of PgR and ER in fact does improve the reliability of ER measurement alone in predicting patient response to endocrine therapies (8).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
E. V. Jensen, G. E. Block, S. Smith, K. Kyser, and E. R. DeSombre, Estrogen receptors and breast cancer response to adrenalectomy, Natl. Cancer Inst. Monographs 34: 55 (1971).
W. L. McGuire, P. P. Carbone, M. E. Sears, and G. C. Escher, Estrogen receptors in human breast cancer: An overview, in: “Estrogen receptors in human breast cancer,” W. L. McGuire, P. P. Carbone, and E. P. Vollmer, eds., p.1., Raven Press, New York (1975).
B. S. Katzenellenbogen and J. Gorski, Estrogen action on syntheses of macromolecules in target cells, in: “Biochemical Actions of Hormones,” G. Litwack, ed., p. 187, Academic Press, New York (1975).
W. L. McGuire and K. B. Horwitz, Progesterone receptors in breast cancer, in: “Hormones, Receptors and Breast Cancer,” W. L. McGuire, ed., p. 31, Raven Press, New York (1978).
K. B. Horwitz and W. L. McGuire, Progesterone and progesterone receptors in experimental breast cancer, Cancer Res. 37: 1733 (1977).
A. J. M. Koenders, A. Geurts-Moespot, S. J. Zolinger, and T. J. Benraad, Progesterone and estradiol receptors in DMBA-induced mammary tumors before and after ovariectomy and after subsequent estradiol administration, in: “Progesterone Receptors in Normal and Neoplastic Tissues,” W. L. McGuire, J. P. Raynaud, and E. E. Baulier, eds. p. 71, Raven Press, New York (1977).
K. B. Horwitz and W. L. McGuire, Estrogen control of progesterone receptor in human breast cancer, J. Biol. Chem. 253: 2223 (1978).
D. P. Edwards, G. C. Chamness, and W. L. McGuire, Estrogen and progesterone receptor proteins in breast cancer, Biochemica et Biophysica Acta 560: 457 (1979).
I. Margot, R. J. Milholland, and F. Rosen, Mammary cancer: Selective action of the estrogen receptor complex, Science 203: 361 (1979).
D. P. Edwards, S. R. Murthy, and W. L. McGuire, Estrogen and antiestrogen effects on DNA polymerase in human breast cancer, Cancer Res., in press (1980).
S. Jozan, C. Moure, M. Gillois, and F. Bayard, Effects of estrone on cell proliferation of a human breast cancer (MCF-7) in long term tissue culture, J. Steroid Biochem. 10: 341 (1979).
M. Lippman, G. Bolan, and K. Huff, The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long term tissue culture, Cancer Res. 38: 4595 (1976).
K. Burton, A study of conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of DNA. Biochem. J. 62: 315 (1956).
D. T. Zava and W. L. McGuire, Estrogen receptor: Unoccupied sites in nuclei of a human breast cancer cell line, J. Biol. Chem. 252: 3703 (1977).
D. T. Zava and W. L. McGuire, Androgen action through estrogen receptor in a human breast cancer cell line, Endocrinology 103: 624 (1978).
K. B. Horwitz and W. L. McGuire, Nuclear mechanisms of estrogen action: Effects of estradiol and antiestrogen on cytoplasmic and nuclear estrogen receptors and nuclear receptor processing, J. Biol. Chem. 253: 8185 (1978).
A. Weissbach, Eukaryotic DNA polymerases, Ann. Rev. Biochem. 46: 25 (1977).
J. N. Harris and J. Gorski, Estrogen stimulation of DNA-dependent DNA polymerase activity in immature rat uterus, Mol. Cell. Endocrinol. 10: 293 (1978).
H. J. Rohde, W. E. G. Muller, and R. K. Zahn, Alterations of DNA-dependent DNA polymerase activities in the immature quail oviduct in response to estrogen stimulation, Nuclei Acid Res. 2: 2101 (1975).
R. L. Sutherland, M.-C. Legeau, P. H. Schmelck, and E. E. Baulieu, Synergistic and antagonistic effects of progesterone and estrogen on estrogen receptor concentration and DNA polymerase activity in chick oviduct, FEBS Letters 79: 253 (1977).
M. D. Walker, A. M. Kaye, and B. R. Fridlender, Age-dependent stimulation by estradiol-176 of DNA polymerase a in immature rat uterus, FEBS Letters 92: 25 (1978).
D. P. Edwards, D. J. Adams, N. Savage, and W. L. McGuire, Estrogen induced synthesis of specific proteins in human breast cancer cells, Biochem. Biophys. Res. Comm., in press (1980).
M. D. Walker, I. Gozes, A. M. Kaye, N. Reiss, and U. Z. Littauer, The estrogen-induced protein: Quantitation by autoradiography of polyacrylamide gels, J. Steroid Biochem. 7: 1083 (1976).
B. S. Katzenellenbogen and J. Gorski, Estrogen action in vitro: Induction of the synthesis of a specific uterine protein, J. Biol. Chem. 247: 1299 (1972).
M. L. Groves and W. G. Gordon, The major component of human casein: A protein phosphorylated at different levels, Arch. Biochem. Biophys. 140: 47 (1970).
B. Westley and H. Rochefort, Estradiol induced proteins in the MCF-7 human breast cancer cell line, Biochem. Biophys. Res. Comm. 90: 410 (1979).
W. B. Butler, W. L. Kirkland, and T. L. Jorgensen, Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7), Biochem. Biophys. Res. Comm. 90: 1328 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Edwards, D.P., Adams, D.J., McGuire, W.L. (1982). Estrogen Regulation of Growth and Specific Protein Synthesis in Human Breast Cancer Cells in Tissue Culture. In: Leavitt, W.W. (eds) Hormones and Cancer. Advances in Experimental Medicine and Biology, vol 138. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7192-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-7192-6_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-7194-0
Online ISBN: 978-1-4615-7192-6
eBook Packages: Springer Book Archive